7 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Diabetes #Diabetic ... #Dosing #Renal ... Impairment #CKD #Table
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Medications for Tobacco Cessation ... , Varenicline (tablet ... release (SR) (tablet ... Smoking #Tobacco #Cessation ... #Agents #Dosing
Pharmacotherapy for Smoking Cessation - Table of Short and Long-Acting Agents:

Long Acting: Nicotine Patch, Buproprion, Varenicline
Short
Pharmacotherapy for Smoking Cessation ... - Table of Short ... and Long-Acting Agents ... Therapy #Comparison #Table ... #Agents #Dosing
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... effects include GI ... in the GI tract ... #Pharmacology #Dosing ... #Diabetes #DM2
Hypomagnesemia - Etiologies by Mechanism

Decreased GI Uptake 
 - Poor dietary intake (particularly common in alcoholics)
Mechanism Decreased GI ... hypomagnesemia Excessive GI ... - Uncontrolled diabetes ... Low #Magnesium #Table ... Classification #Causes #Workup
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... Otherwise, it works ... drug to remain stable ... known to have GI ... #semaglutide #Diabetes
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
HER2 agents cause ... attributed to HER2 agents ... reversible with cessation ... hypertension, diabetes ... every 3 months during